Tissue Remodeling and Inflammation during Peritoneal Dialysis: Catheter versus Fluid

Fresenius Medical Care Annual Report 2008: Dialysis Market. Available at: http://reports.fmc-ag.com/reports/fmc/annual/2008/gb/English/401040/dialysis-market.html

Lameire N. , Van Biesen W. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 2010; 6: 75–82.

Di Paolo N. , Garosi G. , Petrini G. , Monaci G. Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit. Nephron 1996; 74: 594–9.

Williams J.D. , Craig K.J. , Topley N. , Von Ruhland C. , Fallon M. , Newman G.R. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470–9.

Williams J.D. , Craig K.J. , von Ruhland C. , Topley N. , Williams G.T. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88: S43–9.

Mateijsen M.A. , van der Wal A.C. , Hendriks P.M. , Zweers M.M. , Mulder J. , Struijk D.G. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517–25.

Schilte M.N. , Celie J.W. , ter Wee P.M. , Beelen R.H. , van den Born J. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int 2009; 29: 605–17.

Zareie M. , Keuning E.D. , ter Wee P.M. , Schalkwijk C.G. , Beelen R.H.J. , van den Born J. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Nephrol Dial Transplant 2006; 21: 208–16.

Flessner M.F. , Credit K. , Henderson K. , Vanpelt H.M. , Potter R. , He Z. Peritoneal changes after exposure to sterile solutions by catheter. J Am Soc Nephrol 2007; 18: 2294–302.

Zakaria el R. , Matheson P.J. , Hurt R.T. , Garrison R.N. Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence. Adv Perit Dial 2008; 24: 7–15.

Ash S.R. Chronic peritoneal dialysis catheters: challenges and design solutions. Int J Artif Organs 2006; 29: 85–94.

Lo W.K. , Lui S.L. , Li F.K. , Choy B.Y. , Lam M.F. , Tse K.C. A prospective randomized study on three different peritoneal dialysis catheters. Perit Dial Int 2003; 23(Suppl 2): S127–31.

Diaz-Buxo J.A. Complications of peritoneal dialysis catheters: early and late. Int J Artif Organs 2006; 29: 50–8.

Twardowski Z.J. History of peritoneal access development. Int J Artif Organs 2006; 29: 2–40.

Kazory A. , Cendan J.C. , Hollen T.L. , Ross E.A. Primary malfunction of a peritoneal dialysis catheter due to encasement in an encapsulating sheath. Perit Dial Int 2007; 27: 707–9.

Cox S.D. , Walsh S.B. , Yaqoob M.M. , Fan S.L. Predictors of survival and technique success after reinsertion of peritoneal dialysis catheter following severe peritonitis. Perit Dial Int 2007; 27: 67–73.

Lam M.F. , Lo W.K. , Tse K.C. , Yip T.P. , Lui S.L. , Chan T.M. Retroperitoneal leakage as a cause of acute ultrafiltration failure: its associated risk factors in peritoneal dialysis. Perit Dial Int 2009; 29: 542–7.

Ersoy F.F. Improving technique survival in peritoneal dialysis: what is modifiable? Perit Dial Int 2009; 29(Suppl 2): S74–7.

Nolan T.E. , Klein H.J. Methods in vascular infusion biotechnology in research with rodents. ILAR J 2002; 43: 175–82.

Thodis E. , Passadakis P. , Ossareh S. , Panagoutsos S. , Vargemezis V. , Oreopoulos D.G. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment. Int J Artif Organs 2003; 26: 698–714.

Rao S.P. , Oreopoulos D.G. Unusual complications of a polyurethane PD catheter. Perit Dial Int 1997; 17: 410–12.

Perakis K.E. , Stylianou K.G. , Kyriazis J.P. , Mavroeidi V.N. , Katsipi I.G. , Vardaki E.A. Long-term complication rates and survival of peritoneal dialysis catheters: the role of percutaneous versus surgical placement. Semin Dial 2009; 22: 569–75.

Perl J. , Jassal S.V. , Bargman J.M. Persistent peritoneal dialysis catheter exit-site leak in a patient receiving maintenance immunosuppression with sirolimus. Clin Transplant 2008; 22: 672–3.

Negoi D. , Prowant B.F. , Twardowski Z.J. Current trends in the use of peritoneal dialysis catheters. Adv Perit Dial 2006; 22: 147–52.

Flessner M.F. , Credit K. , Richardson K. , Potter R. , Li X. , He Z. Peritoneal inflammation after twenty-week exposure to dialysis solution: effect of solution versus catheter-foreign body reaction. Perit Dial Int 2010; 30: 284–93.

Glik A. , Douvdevani A. T lymphocytes: the “cellular” arm of acquired immunity in the peritoneum. Perit Dial Int 2006; 26: 438–48.

Margetts P.J. , Gyorffy S. , Kolb M. , Yu L. , Hoff C.M. , Holmes C.J. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002; 13: 721–8.

Wieczorowska-Tobis K. , Brelinska R. , Breborowicz A. , Oreopoulos D.G. Morphologic aspects of chronic peritoneal dialysis in a rat model. Perit Dial Int 2001; 21(Suppl 3): S342–4.

Mortier S. , Lameire N.H. , De Vriese A.S. Animal models in peritoneal dialysis research: a need for consensus. Perit Dial Int 2005; 25: 16–24.

Lee H.T. , Kim M. , Kim M. , Kim N. , Billings F.T. , D'Agati V.D. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 2007; 293: F713–F722.

Hofstetter C. , Flondor M. , Boost K.A. , Koehler P. , Bosmann M. , Pfeilschifter J. A brief exposure to isoflurane (50 s) significantly impacts on plasma cytokine levels in endotoxemic rats. Int Immunopharmacol 2005; 5: 1519–22.